Ma. Carrasco et al., CHANGES IN IP3 METABOLISM DURING SKELETAL-MUSCLE DEVELOPMENT IN-VIVO AND IN-VITRO, Comparative biochemistry and physiology. B. Comparative biochemistry, 116(2), 1997, pp. 173-181
We have investigated whether IP3 metabolism presents particular change
s during critical stages of muscle development. With this aim, we have
measured IP3 formation through phospholipase C activity, IP3 removal
through IP3 5-phosphatase and IP3 3-kinase activities, as well as IP3
mass, during myogenesis in vivo and in vitro. In developing rat skelet
al muscle, both IP3 3-kinase and 5 phosphatase activities were relativ
ely constant from embryonary day 15, the earliest age studied, to post
natal day 10; 5-phosphatase decreased upon further development. A tran
sient, major increase in phospholipase C activity was evident at embry
onary day 18 while a non-significant increase in IP3 mass was detected
at this embrionary age. In rat skeletal muscle in primary culture, al
l enzyme activities as well as the mass of IP3 increased significantly
in myotubes compared to myoblasts. Myotubes incubated with calcitonin
gene-related peptide, responded with a transient increase in IP3 mass
after 2 to 10 sec; the CGRP induced increase being completely blocked
by U-73122, a phospholipase C inhibitor. Furthermore, IP3 mass increa
sed within 1 hr after exposure to differentiating agents of both RCMH
cells, a line derived from normal human skeletal muscle, and C2C12 cel
ls. These results indicate that changes in IP3 metabolism can be corre
lated to critical stages of muscle development and differentiation, su
ggesting a possible role for IP3 in these processes. Copyright (C) 199
7 Elsevier Science Inc.